FDA issues public safety notification after exosome treatment sickens patients in Nebraska
from By Lynn Hetzler
Last month, the Food and Drug Administration (FDA) issued a public safety notification regarding exosome products following multiple reports of serious adverse effects experienced by patients in Nebraska who received treatment with unapproved products. Derived from endosomes and present in all body fluids, exosomes are a form of extracellular vesicle. Clinics administer exosome therapies through intravenous injection, inhalation or injection into joints or soft tissue.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063